A Prospective Study Analyzing Short Term Effects of Intravitreal versus Intracameral Bevacizumab on Neovascular Glaucoma. mfm. 2024;28(4). Accessed November 17, 2025. https://medicalforummonthly.com/index.php/mfm/article/view/3985